Product
Etoposide, Doxorubicin, Cisplatin, Mitotane, Megestrol Acetate
1 clinical trial
1 indication
Indication
Adrenocortical CancerClinical trial
Prospective, Phase II Study to Evaluate the Efficacy of Addition of Progesterone to Standard Chemotherapy According to Etoposide-Doxorubicin-Cisplatin Scheme Plus Mitotane (EDP-M) in Patients With Advanced Adrenocortical Carcinoma (ACC)Status: Recruiting, Estimated PCD: 2027-06-08